Alto Neuroscience ANRO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.24M-73.0% | -$16.18M-6.5% | -$14.18M+15.5% | -$17.71M-10.5% | -$15.17M-13.1% | ||
| $184K+7.6% | $157K-7.6% | $200K0.0% | $100K0.0% | $171K+76.3% | ||
| $2.82M+43.5% | $1.95M+24.3% | $2.19M+9.6% | $2.01M+6.2% | $1.97M-9.7% | ||
| -$27.09M-63.6% | -$11.52M+11.6% | -$9.92M+15.4% | -$13.78M-17.8% | -$16.56M-50.7% | ||
| $556K+2,217% | —— | —— | —— | $24K-89.3% | ||
| -$556K-2,217% | —— | —— | —— | -$24K+89.3% | ||
| $0-100% | —— | —— | —— | $10.21M— | ||
| $114.94M+1,159% | $50.19M+102,318% | $153K-88.4% | $613K— | $9.13M-93.2% | ||
| $87.28M+1,268% | $38.67M— | -$9.77M— | -$13.17M— | -$7.48M-106% | ||
| -$27.65M-66.7% | -$11.52M+14.9% | -$9.92M+22.1% | -$13.78M-14.5% | -$16.58M-47.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alto Neuroscience generate?
- Alto Neuroscience (ANRO) generated -$62.3M in operating cash flow over the trailing twelve months.
- What is Alto Neuroscience's free cash flow?
- After $2.1M of capital expenditures, Alto Neuroscience's free cash flow was -$62.9M over the trailing twelve months, down 14.6% year over year.
- Where does Alto Neuroscience's cash flow data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.